Emerging targets and therapeutic approaches for the treatment of osteoarthritis pain

Wahida Rahman1, Anthony H Dickenson

  • 1Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK.

Abstract

Insights

New therapeutic targets show promise for managing osteoarthritis pain by addressing aberrant nerve pathway excitability. Personalized treatment approaches, guided by patient sensory phenotyping, are crucial for developing more effective analgesics.

Area of Science:

  • Pain research
  • Pharmacology
  • Neurology

Background:

  • Osteoarthritis (OA) pain is complex and poorly managed by current analgesics.
  • Aberrant excitability in peripheral and central pain pathways contributes significantly to OA pain.
  • Existing treatments often fail to provide adequate pain relief for OA patients.

Purpose of the Study:

  • To review emerging therapeutic targets for osteoarthritis pain.
  • To discuss novel approaches for developing improved analgesics.
  • To highlight the potential of mechanism-based OA pain management.

Main Methods:

  • Review of current literature on osteoarthritis pain mechanisms.
  • Analysis of emerging molecular and cellular targets for pain modulation.
  • Exploration of novel therapeutic strategies including pharmacological and non-pharmacological interventions.

Main Results:

  • Modulation of nerve growth factor, ion channels (sodium, calcium), and TRPV1 shows therapeutic potential.
  • Enhancing inhibitory mechanisms via cannabinoid and descending modulatory systems offers a promising avenue.
  • Somatosensory phenotyping may predict patient response to specific OA pain treatments.

Conclusions:

  • Identifying new targets is essential for advancing OA pain management.
  • Individualized, mechanism-based treatment strategies are needed for effective OA pain control.
  • Incorporating sensory phenotyping in clinical trials can guide personalized analgesic development.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.2K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
11.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K